TY - JOUR
T1 - New modalities of transdermal testosterone replacement
AU - Basaria, Shehzad
AU - Dobs, Adrian S.
PY - 2003/9/9
Y1 - 2003/9/9
N2 - Hypogonadism, irrespective of its etiology, has a negative impact on various physiologic parameters. These parameters may improve with testosterone replacement therapy. Before 1990, intramuscular testosterone esters were the principal modality of testosterone replacement in men with hypogonadism. Although effective, they have a non-physiologic pharmacokinetic profile. Recently, transdelmal preparations of testosterone have become widely available. These include a scrotal patch, non-scrotal patches and, the most recent development, a gel. Several studies have shown that transdermal testosterone replacement is physiologic, efficacious and has a good safety profile. Transdermal testosterone replacement improves bone mass and lean body mass, decreases fat mass, and improves mood and sexual function. There are no harmful effects on the prostate and lipids. Acne, polycythemia and gynecomastia are less common with this form of therapy than with the intramuscular esters.
AB - Hypogonadism, irrespective of its etiology, has a negative impact on various physiologic parameters. These parameters may improve with testosterone replacement therapy. Before 1990, intramuscular testosterone esters were the principal modality of testosterone replacement in men with hypogonadism. Although effective, they have a non-physiologic pharmacokinetic profile. Recently, transdelmal preparations of testosterone have become widely available. These include a scrotal patch, non-scrotal patches and, the most recent development, a gel. Several studies have shown that transdermal testosterone replacement is physiologic, efficacious and has a good safety profile. Transdermal testosterone replacement improves bone mass and lean body mass, decreases fat mass, and improves mood and sexual function. There are no harmful effects on the prostate and lipids. Acne, polycythemia and gynecomastia are less common with this form of therapy than with the intramuscular esters.
UR - http://www.scopus.com/inward/record.url?scp=0042861376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0042861376&partnerID=8YFLogxK
U2 - 10.2165/00024677-200302010-00001
DO - 10.2165/00024677-200302010-00001
M3 - Review article
C2 - 15871550
AN - SCOPUS:0042861376
SN - 1175-6349
VL - 2
SP - 1
EP - 9
JO - Treatments in Endocrinology
JF - Treatments in Endocrinology
IS - 1
ER -